Recombinant Humanized IgG4 Monoclonal Antibody Against pHERV-W Envelope Protein
- Name
- Recombinant Humanized IgG4 Monoclonal Antibody Against pHERV-W Envelope Protein
- Accession Number
- DBCAT005762
- Description
Not Available
- Drugs
Drug Drug Description Temelimab Temelimab is under investigation in clinical trial NCT02782858 (Clinical Trial Assessing the HERV-W Env Antagonist Gnbac1 for Efficacy in MS). - Drugs & Drug Targets
Drug Target Type